Skip to main content
Log in

Returning to PD after kidney transplant failure is a valuable option

  • Nephrology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Purpose

There is a paucity of data on the prognosis for patients returning to peritoneal dialysis (PD) after a failed transplant. PD has an advantage over hemodialysis in preserving residual renal function, which is associated with better outcomes.

Methods

We have reviewed the electronic charts of patients on PD in a tertiary academic hospital for the last 8 years. We have compared technique survival, peritonitis-free survival, and residual diuresis in two groups: patients with graft failure which returned to PD (PD-KTx, N = 18) and patients starting PD for other causes (PD-not KTx, N = 163).

Results

The median follow-up was similar between groups [42(16,71) in PD-not KTx vs. 48(22,90) months in PD-KTx, p = 0.293]. Kaplan–Meier survival comparing PD-KTx and PD-not KTx showed no difference in technique survival (p = 0.196), and peritonitis-free survival (log-rank 0.238), which were confirmed in a fully adjusted Cox regression. Diuresis at baseline and at the end of the first year was similar between groups (p = 0.799 and p = 0.354, respectively). Six out of 18 patients from the PD-KTx group had the immunosuppression maintained and none of those had peritonitis. The reduction of diuresis across the first year of PD was significant for all patients, except for those on continued immunosuppressive therapy.

Conclusion

PD is a worthy dialysis alternative after a failed kidney transplant, providing similar outcomes when compared to patients who started PD for other reasons.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Availability of data and materials

Data are available for reviewers and authors for any reasonable reason.

References

  1. Winkelmayer WC, Weinstein MC, Mittleman MA, Glynn RJ, Pliskin JS (2002) Health economic evaluations: the special case of end-stage renal disease treatment. Med Decis Making 22(5):417–430. https://doi.org/10.1177/027298902236927

    Article  PubMed  Google Scholar 

  2. Budhram B, Sinclair A, Komenda P, Severn M, Sood MM (2020) A comparison of patient-reported outcome measures of quality of life by dialysis modality in the treatment of kidney failure: a systematic review. Can J Kidney Health Dis 7:2054358120957431. https://doi.org/10.1177/2054358120957431

    Article  PubMed  PubMed Central  Google Scholar 

  3. Wong B, Ravani P, Oliver MJ, Holroyd-Leduc J, Venturato L, Garg AX, Quinn RR (2018) Comparison of patient survival between hemodialysis and peritoneal dialysis among patients eligible for both modalities. Am J Kidney Dis 71(3):344–351. https://doi.org/10.1053/j.ajkd.2017.08.028

    Article  PubMed  Google Scholar 

  4. Tang SCW, Lai KN (2020) Peritoneal dialysis: the ideal bridge from conservative therapy to kidney transplant. J Nephrol 33(6):1189–1194. https://doi.org/10.1007/s40620-020-00787-0

    Article  PubMed  PubMed Central  Google Scholar 

  5. Thiery A, Severac F, Hannedouche T, Couchoud C, Do VH, Tiple A, Bechade C, Sauleau EA, Krummel T, registry R (2018) Survival advantage of planned haemodialysis over peritoneal dialysis: a cohort study. Nephrol Dial Transplant 33(8):1411–1419. https://doi.org/10.1093/ndt/gfy007

    Article  CAS  PubMed  Google Scholar 

  6. da Costa LA, Andreoli MCC, Carvalho AB, Draibe SA, Pestana JOM, Canziani MEF (2020) Clinical outcomes of incident peritoneal dialysis patients coming from kidney transplantation program: a case-control study. PLoS ONE 15(1):e0227870. https://doi.org/10.1371/journal.pone.0227870

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Benomar M, Vachey C, Lobbedez T, Henriques J, Ducloux D, Vernerey D, Courivaud C (2019) Peritoneal dialysis after kidney transplant failure: a nationwide matched cohort study from the French Language Peritoneal Dialysis Registry (RDPLF). Nephrol Dial Transplant 34(5):858–863. https://doi.org/10.1093/ndt/gfy290

    Article  CAS  PubMed  Google Scholar 

  8. Smak Gregoor PJ, Zietse R, van Saase JL, op de Hoek CT, IJzermans JN, Lavrijssen AT, de Jong GM, Kramer P, Weimar W (2001) Immunosuppression should be stopped in patients with renal allograft failure. Clin Transplant 15(6):397–401. https://doi.org/10.1034/j.1399-0012.2001.150606.x

    Article  CAS  PubMed  Google Scholar 

  9. Perl J, Bargman JM, Davies SJ, Jassal SV (2008) Clinical outcomes after failed renal transplantation-does dialysis modality matter? Semin Dial 21(3):239–244. https://doi.org/10.1111/j.1525-139X.2008.00441.x

    Article  PubMed  Google Scholar 

  10. Coronel F, Florit E, Cigarran-Guldris S, Herrero-Calvo JA, Delgado-Cordova M, Rodriguez-Cubillo B (2014) Early kidney transplant failure and return to peritoneal dialysis: preliminary study of permeability and dialysis efficacy. Nefrologia 34(1):105–109. https://doi.org/10.3265/Nefrologia.pre2013.Oct.11732

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to thank Fatima Libanio for her assistance in retrieving the data from the electronic charts.

Funding

The author(s) RMAM and RME disclosed receipt of support from CNPQ (Conselho Nacional de Desenvolvimento Científico e Tecnológico), grant numbers 303545/2020-8 and 305106/2018-0, respectively). This financial support had no role in study design; collection, analysis, and interpretation of data; writing the report; and the decision to submit the report for publication.

Author information

Authors and Affiliations

Authors

Contributions

AGJTM and RME researched literature and conceived the study. AGJTM, GSBB, DDPVRC, and RGR helping collect the data. RME wrote the first draft of the manuscript. LKA, BJP, HA, and RMAM gave important intellectual contributions. All authors reviewed and edited the manuscript and approved the final version of the manuscript.

Corresponding author

Correspondence to Rosilene M. Elias.

Ethics declarations

Conflict of interest

The author declare that they have no conflict of interest.

Ethical approval

Ethical approval for this study was obtained from *Comissão de Ética para análise de projetos de pesquisa – CAPpesq (45163715.4.0000.0068).

Consent to participate

Written informed consent was not obtained from subjects since was waived by the Research Ethical Board.

Consent to publication

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Melo, A.G.J.T., Barbosa, G.S.B., V. R. Cortes, D.D.P. et al. Returning to PD after kidney transplant failure is a valuable option. Int Urol Nephrol 54, 1123–1126 (2022). https://doi.org/10.1007/s11255-021-02980-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-021-02980-x

Keywords

Navigation